STAT

STAT+: Pharmalittle: FDA approves first gene therapy for Duchenne muscular dystrophy; states join FTC to stop Amgen deal

The states of California, New York, Illinois, Minnesota, Washington, and Wisconsin have joined a Federal Trade Commission lawsuit to stop Amgen from buying Horizon Therapeutics.
Source: Alex Hogan/STAT

And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is exceedingly modest. Rain, , and . And what about you? Now that summer has officially arrived, perhaps this is an opportunity to plan a well-deserved getaway. While you ponder the possibilities, you could get a head start by enjoying the great outdoors, hit a few good eateries, or maybe visit a museum or two. Or if energy levels are low, curl up in front of the telly. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon…

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.

Related Books & Audiobooks